Eva Coleman
Psychiatric/Mental Health · Chattanooga, TNNPI 1528766797
Payments from drug & device makers
Across 125 payments — averaging $21.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$581
- AbbVie$373
- E.r. Squibb & Sons, L.L.C.$276
- Alkermes, Inc.$255
- Otsuka America Pharmaceutical, Inc.$244
- Vanda Pharmaceuticals Inc.$210
- plus $713 from 14 others
What the payments were for
- Food & beverage$2,643100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 23 | $581 |
| AbbVie | 26 | $373 |
| E.r. Squibb & Sons, L.L.C. | 11 | $276 |
| Alkermes, Inc. | 11 | $255 |
| Otsuka America Pharmaceutical, Inc. | 12 | $244 |
| Vanda Pharmaceuticals Inc. | 6 | $210 |
| Lundbeck LLC | 7 | $158 |
| Teva Pharmaceuticals USA, Inc. | 6 | $137 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $108 |
| Axsome Therapeutics, Inc. | 4 | $64 |
| Noven Therapeutics, LLC | 2 | $42 |
| Abiomed | 1 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Luye Pharma (USA) Ltd. | 1 | $29 |
| Ironshore Pharmaceuticals Inc. | 1 | $21 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $20 |
| Harmony Biosciences LLC | 1 | $18 |
| Tris Pharma Inc | 1 | $18 |
| Almatica Pharma LLC | 1 | $17 |
| Corium, LLC | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,651 in reported general payments places this provider in the 75th percentile of 1,167 psychiatric/mental health providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 15 | $23,048 |
| Lurasidone Hcl | 16 | $14,879 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 32 | $5,919 |
| VyvanseLisdexamfetamine Dimesylate | 11 | $4,366 |
| Aripiprazole | 37 | $4,311 |
| Bupropion XlBupropion Hcl | 39 | $2,138 |
| Buspirone Hcl | 80 | $2,032 |
| Duloxetine Hcl | 70 | $1,805 |
| Clozapine | 30 | $1,565 |
| Doxepin Hcl | 71 | $1,177 |
| Mirtazapine | 48 | $1,082 |
| Trazodone Hcl | 117 | $998 |
| Propranolol Hcl | 43 | $943 |
| Quetiapine Fumarate | 74 | $861 |
| Hydroxyzine Hcl | 37 | $718 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $373 | $23,04815 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $30 | $4,36611 claims |
| Almatica Pharma LLCSertraline Hcl | $17 | $47655 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,167 psychiatric/mental health providers in Tennessee.
Other psychiatric/mental health in Chattanooga
- Joshua ThompsonChattanooga$262K
- Jason HamrickChattanooga$17K
- Tina FoxChattanooga$14K
- Trena LawsonChattanooga$13K
- Erin LawsonChattanooga$10K
- Laura MelaroBolivar$682K
- Fay BembryJohnson City$449K
- Kristian DambrinoNashville$449K
- Mary AllenMemphis$422K
- Lauren HansenNashville$263K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.